| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hilde T Juvodden, Dag Alnæs, Martina J Lund, Ingrid Agartz, Ole A Andreassen, Espen Dietrichs, Per M Thorsby, Lars T Westlye, Stine Knudse. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives. Sleep. vol 41. issue 10. 2019-09-24. PMID:30016530. |
to assess white matter involvement in h1n1-vaccinated hypocretin deficient patients with narcolepsy type 1 (nt1) compared with first-degree relatives (a potential risk group) and healthy controls. |
2019-09-24 |
2023-08-13 |
Not clear |
| Sebjørg Hesla Nordstrand, Berit Hjelde Hansen, Yusman Kamaleri, Kristian Bernhard Nilsen, Terje Rootwelt, Tor-Ivar Karlsen, Stine Knudse. Changes in quality of life in individuals with narcolepsy type 1 after the H1N1-influenza epidemic and vaccination campaign in Norway: a two-year prospective cohort study. Sleep medicine. vol 50. 2019-09-13. PMID:30075393. |
we aimed to describe changes in hrqol after two years of multidisciplinary follow-up in a cohort of mainly post-h1n1 vaccination narcolepsy type-1 (nt1) patients in norway. |
2019-09-13 |
2023-08-13 |
Not clear |
| Adriana Bosco, Régis Lopez, Lucie Barateau, Sofiene Chenini, Carole Pesenti, Jean-Louis Pépin, Isabelle Jaussent, Yves Dauvillier. Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy. Neurology. vol 90. issue 6. 2019-07-23. PMID:29321233. |
to assess the effect of psychostimulant treatments on the 24-hour blood pressure (bp) profile of patients with narcolepsy type 1 (nt1). |
2019-07-23 |
2023-08-13 |
Not clear |
| Marco Filardi, Fabio Pizza, Elena Antelmi, Raffaele Ferri, Vincenzo Natale, Giuseppe Plazz. In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: an actigraphic study. Sleep. vol 41. issue 6. 2019-05-15. PMID:29522206. |
sodium oxybate (sxb) is a gabaergic agent widely used as off-label treatment in pediatric type 1 narcolepsy (nt1). |
2019-05-15 |
2023-08-13 |
Not clear |
| Natasja Wulff Pedersen, Anja Holm, Nikolaj Pagh Kristensen, Anne-Mette Bjerregaard, Amalie Kai Bentzen, Andrea Marion Marquard, Tripti Tamhane, Kristoffer Sølvsten Burgdorf, Henrik Ullum, Poul Jennum, Stine Knudsen, Sine Reker Hadrup, Birgitte Rahbek Kornu. CD8 Nature communications. vol 10. issue 1. 2019-04-08. PMID:30783092. |
cd8 narcolepsy type 1 (nt1) is a neurological sleep disorder, characterized by the loss of hypocretin/orexin signaling in the brain. |
2019-04-08 |
2023-08-13 |
Not clear |
| Monica Moresco, Fabio Pizza, Elena Antelmi, Giuseppe Plazz. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy. Current drug metabolism. vol 19. issue 13. 2019-02-28. PMID:29512449. |
narcolepsy type 1 (nt1) is a chronic neurologic disorder defined by excessive daytime sleepiness, cataplexy, sleep paralysis, hallucinations and disrupted nocturnal sleep, typically with onset during childhood/ adolescence. |
2019-02-28 |
2023-08-13 |
Not clear |
| P Medrano-Martinez, M J Ramos-Platon, R Peraita-Adrado. [Neuropsychological alterations in narcolepsy with cataplexy: a review]. Revista de neurologia. vol 66. issue 3. 2019-01-02. PMID:29368327. |
to describe the current state of the art about the main cognitive deficits that appear in patients affected with narcolepsy with cataplexy (nt1). |
2019-01-02 |
2023-08-13 |
Not clear |
| Régis Lopez, Anis Doukkali, Lucie Barateau, Elisa Evangelista, Sofiene Chenini, Isabelle Jaussent, Yves Dauvillier. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep. vol 40. issue 12. 2018-12-31. PMID:29099966. |
to assess the test-retest reliability of the polysomnography-multiple sleep latency test (psg-mslt) diagnostic classification and measures and to study the determinants of its variability in patients with narcolepsy type 1 (nt1) or with noncataplectic central disorders of hypersomnolence (nchs): type 2 (nt2), idiopathic hypersomnia (ih), and unspecified hypersomnolence (unspecified excessive daytime sleepiness [unseds]). |
2018-12-31 |
2023-08-13 |
Not clear |
| Thomas Rossor, Ming Lim, Kirandeep VanDenEshof, Paul Gringra. Pseudotumor cerebri syndrome in a patient with narcolepsy type 1. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 22. issue 1. 2018-07-02. PMID:29195824. |
type 1 narcolepsy (nt1) is a chronic primary disorder of hypersomnolence characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations and disrupted nocturnal sleep. |
2018-07-02 |
2023-08-13 |
human |
| Lucie Barateau, Roland Liblau, Christelle Peyron, Yves Dauvillier. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS drugs. vol 31. issue 10. 2018-06-07. PMID:28940143. |
narcolepsy type 1 (nt1) is a rare sleep disorder caused by the very specific loss of hypothalamic hypocretin (hcrt)/orexin neurons. |
2018-06-07 |
2023-08-13 |
human |
| Julie Anja Engelhard Christensen, Miki Nikolic, Mathias Hvidtfelt, Birgitte Rahbek Kornum, Poul Jennu. Sleep spindle density in narcolepsy. Sleep medicine. vol 34. 2018-03-07. PMID:28522097. |
patients with narcolepsy type 1 (nt1) show alterations in sleep stage transitions, rapid-eye-movement (rem) and non-rem sleep due to the loss of hypocretinergic signaling. |
2018-03-07 |
2023-08-13 |
Not clear |
| Julie Anja Engelhard Christensen, Miki Nikolic, Mathias Hvidtfelt, Birgitte Rahbek Kornum, Poul Jennu. Sleep spindle density in narcolepsy. Sleep medicine. vol 34. 2018-03-07. PMID:28522097. |
we aimed to evaluate whether the sleep spindle (ss) density is altered in patients with nt1 compared to controls and patients with narcolepsy type 2 (nt2). |
2018-03-07 |
2023-08-13 |
Not clear |
| Y Dauvilliers, C Gaig, L Barateau, F Graus, A Iranzo, R Lopez, J Santamari. Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis. Scientific reports. vol 6. 2018-01-26. PMID:27143278. |
frequency and mechanisms underlying the association between narcolepsy type 1 (nt1) and psychosis remain unclear with potential role for a common immune pathway. |
2018-01-26 |
2023-08-13 |
Not clear |
| Yves Dauvilliers, Elisa Evangelista, Regis Lopez, Lucie Barateau, Sabine Scholz, Barbara Crastes de Paulet, Bertrand Carlander, Isabelle Jaussen. Vitamin D deficiency in type 1 narcolepsy: a reappraisal. Sleep medicine. vol 29. 2018-01-05. PMID:28153207. |
narcolepsy type 1 (nt1) is considered to be an immune-mediated disease in which environmental factors, such as vitamin d, might play a major role. |
2018-01-05 |
2023-08-13 |
Not clear |
| M Mazzetti, C Bellucci, C Cipolli, F Pizza, P M Russo, G Tuozzi, S Vandi, G Plazz. Age-related differences in sleep-dependent consolidation of motor skills in patients with narcolepsy type 1. Sleep medicine. vol 24. 2017-12-18. PMID:27810190. |
to ascertain whether the influence of the altered architecture of sleep in patients with narcolepsy type 1 (ie, with cataplexy: nt1) also varies with age, we compared the performance values of 16 children (aged from nine to 14 years) and 16 adults (aged from 24 to 51 years) on finger tapping task (ftt) after daytime and nighttime periods of sleep in the 24 hours following training. |
2017-12-18 |
2023-08-13 |
human |
| Maren Schrölkamp, Poul J Jennum, Steen Gammeltoft, Anja Holm, Birgitte R Kornum, Stine Knudse. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. vol 13. issue 2. 2017-12-11. PMID:27855741. |
other than hypocretin-1 (hcrt-1) deficiency in narcolepsy type 1 (nt1), the neurochemical imbalance of nt1 and narcolepsy type 2 (nt2) with normal hcrt-1 levels is largely unknown. |
2017-12-11 |
2023-08-13 |
Not clear |
| Virginia Ponziani, Monia Gennari, Fabio Pizza, Antonio Balsamo, Filippo Bernardi, Giuseppe Plazz. Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. vol 12. issue 12. 2017-11-27. PMID:27707443. |
to evaluate the effect of type 1 narcolepsy (nt1) on anthropometric and endocrine features in childhood/adolescence, focusing on patterns and correlates of weight, pubertal development, and growth in treated and untreated patients. |
2017-11-27 |
2023-08-13 |
Not clear |
| Anders Vinther Olsen, Jens Stephansen, Eileen Leary, Paul E Peppard, Hong Sheungshul, Poul Jørgen Jennum, Helge Sorensen, Emmanuel Migno. Diagnostic value of sleep stage dissociation as visualized on a 2-dimensional sleep state space in human narcolepsy. Journal of neuroscience methods. vol 282. 2017-11-16. PMID:28219726. |
type 1 narcolepsy (nt1) is characterized by symptoms believed to represent rapid eye movement (rem) sleep stage dissociations, occurrences where features of wake and rem sleep are intermingled, resulting in a mixed state. |
2017-11-16 |
2023-08-13 |
human |
| Mariusz Sieminski, Kamil Chwojnicki, Tomi Sarkanen, Markku Partine. The relationship between orexin levels and blood pressure changes in patients with narcolepsy. PloS one. vol 12. issue 10. 2017-10-23. PMID:29023559. |
narcolepsy type 1 (nt1) is caused by a deficiency or absence of the neurotransmitter orexin. |
2017-10-23 |
2023-08-13 |
Not clear |
| Francesca Letizia Rocca, Elena Finotti, Fabio Pizza, Francesca Ingravallo, Michela Gatta, Oliviero Bruni, Giuseppe Plazz. Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study. Sleep. vol 39. issue 7. 2017-10-13. PMID:27166243. |
to investigate behavioral aspects and quality of life in children and adolescents with type 1 narcolepsy (nt1). |
2017-10-13 |
2023-08-13 |
Not clear |